These new measures deserve pilot testing to assess feasibility and reliability. The new measures relate to hospital admission unit, long-term blood pressure management, and corticosteroid use for intracranial pressure management. It is recognized that for ICH specifi- cally, improved outcomes are seen in patients who are man- aged in a specialized hospital neurological intensive care unit or stroke unit. It appears that this effect is in addition to the impact of any 1 specific targeted intervention and may indi- cate that hospital units such as these create a milieu in which overall care is optimized.30 32 Although there is not an exist- ing analogous performance measure from other organizations, TJC requires that certified Primary and Comprehensive Stroke Centers have such hospital units. To avoid failing this measure in this ICH performance measure set, hospitals that do not have such units are required to transfer patients in the emer- gency setting to another hospital with these capabilities. This emphasizes the importance of stroke systems of care. A poten- tial challenge related to the implementation of this measure is verification of expertise in such hospital units. The 2015 AHA/ ASA ICH guidelines do not provide specifics for how this can be assessed; TJC indicates that specialized training, includ- ing certification in an educational course such as Emergency Neurological Life Support,33 would be a potential indicator. Hypertension is the most common cause of ICH, and the 2015 AHA/ASA ICH guidelines contain a new prevention- focused recommendation for the initiation of blood pressure control immediately after ICH onset.1,2 The related new perfor- mance measure does not apply to specific targets or agents for acute blood pressure control in patients with ICH in the emer- gency department or intensive care unit. 